DebasishBanerjee St George's University Hospital NHS Foundation TrUnited Kingdom

DebasishBanerjee
Debasish Banerjee is the Clinical Lead of the Department of Renal Medicine and Transplantation and Co-Director of the Translational and Clinical Research Institute at St George's University Hospitals NHS Foundation Trust, with special interest in cardiovascular complications of chronic kidney disease. He established the multidisciplinary CKD-heart failure clinic and Cardio-Kidney-Metabolic clinic in St George’s Hospital. He is a Professor of Renal Medicine and Quality Lead for the MBBS Program at City St George's, University of London.
Institution

Day 1 - Sunday April 14, 2024

Time Session
9 a.m.
10:30 a.m.
Gervasio Soler-Pujol Chairperson gsolerpujol@gmail.comMD
MarioSchiffer Chairperson mario.schiffer@uk-erlangen.deUniversity hospital ErlangenGermany
  • Update in Robotic Kidney Transplantation
    RajeshSivaprakasam Speaker United Kingdom
  • Progress in Xenotransplantation
    MeganSykes Speaker ms3976@cumc.columbia.eduUnited States
  • Antigen-specific Chimeric Antigen Receptor Regulatory T Cells for Use in Solid Organ Transplantation
    CarolineLamarche Speaker caroline.lamarche.1@umontreal.caUniversité de MontréalCanada
  • Post Transplant TMA-pathogenesis and Management
    LilianMonteiro P. Palma Speaker lilian.palma@icloud.comState University of CampinasBrazil
  • Q and A
Hall A
10:30 a.m.
11 a.m.
JonathanBarratt Spotlight Speaker University of Leicester, Leicester, UKUnited Kingdom
Spotlight Stage 1 (exhibition hall)
11 a.m.
12 p.m.
AgnesFogo Chairperson United States
GuillermoRosa Diez Chairperson guillermo.rosadiez@hospitalitaliano.org.arHospital Italiano de Buenos Aires; Argentinean Society of Nephrology; Latinoamerican Society of Nephrology and Hypertension; International Society of NephrologyArgentina
  • My Story
    VictoriaGray Speaker vwright_03@yahoo.comUnited States
  • CrisprCas9 Therapy for Sickle Cell Diseases: How Do We Go from Discovery to Equitable Availability of Gene Therapy for All? Hugh de Wardener Lecture
    Obiageli EuniceNnodu Speaker oennodu@gmail.comUniversity of AbujaNigeria
Hall A
12:15 p.m.
1:15 p.m.
Domingo Casadei Chairperson drdomingocasadei@gmail.com
VivekanandJha Chairperson George Institute for Global Health IndiaIndia
  • How to Achieve Transparent and Regulated Organ Donation and Transplantation
    Maria AmaliaMatamoros Speaker Caja Costarricense del Seguro social Costa Rica
  • Non-resident Foreigners in Argentina: Legal Framework to Prevent Transplant Tourism
    LilianaBisigniano Speaker lbisigniano@incucai.gov.arLiliana Bisigniano MDArgentina
  • How to Handle Cases of Presumed Transplant Tourism
    KenSakai Speaker kensakai@med.toho-u.ac.jpDepartment of Nephrology, Toho University Omori Medical CenterJapan
  • Q and A
Hall C1
2:45 p.m.
3:30 p.m.
ErangaWijewickrama Spotlight Chairperson Faculty of Medicine, University of ColomboSri Lanka
Jose VicenteSanchez Polo Spotlight Chairperson visanpolo@gmail.comRenal Division Social Security Institute. Nephrology Residence Program Coordinator, San Carlos University School of Medicine. Latin-American Society Of Nephrology (SLANH)Guatemala
Magdalena Madero Spotlight Speaker Chief of Nephrology, Instituto Nacional de CardiolMexico
VivekanandJha Spotlight Speaker George Institute for Global Health IndiaIndia
NishanthaNanyakkara Spotlight Speaker nishantha4313@gmail.comSri Lanka
Spotlight Stage 1 (exhibition hall)
3 p.m.
4 p.m.
FelipeInserra Chairperson felipe.inserra@gmail.comArgentina
YelenaDrexler Chairperson yrd6@miami.eduUniversity of Miami Miller School of MedicineUnited States
  • New Insights into the Mechanisms of Kidney Injury in the CRS
    WendyMccallum Speaker wmccallum@tuftsmedicalcenter.orgUnited States
  • Novel Pharmacological Treatments of the CRS
    MarkSarnak Speaker msarnak@tuftsmedicalcenter.orgTufts Medical CenterUnited States
  • Device-related Treatment for CRS
    ClaudioRonco Speaker cronco@goldnet.itInternational Renal Research Institute of VicenzaItaly
  • Q and A
Hall D
4 p.m.
4:30 p.m.
BradRovin Spotlight Speaker The Ohio State UniversityUnited States
UptalPatel Spotlight Speaker United States
Spotlight Stage 1 (exhibition hall)
4:30 p.m.
5:30 p.m.
MaartenTaal Chairperson University of NottinghamUnited Kingdom
RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
  • Big Data Lab
  • Patient-reported Outcome Measures: How Do Patients Experience CKD?
    AdeeraLevin Speaker University of British Columbia and Providence Health CareCanada
  • Trial Simulation Using Observational Data
    AngeloKaraboyas Speaker angelo.karaboyas@arborresearch.orgArbor Research Collaborative for HealthUnited States
  • Using Routinely Collected Big Datasets for Clinical Research in CKD: Opportunities and Challenges
    DorotheaNitsch Speaker London School of Hygiene & Tropical MedicineUnited Kingdom
  • Q and A
Hall C4

Day 2 - Monday April 15, 2024

Time Session
12:15 p.m.
1:15 p.m.
RobertoPecoits Filho Chairperson Arbor Research Collaborative for HealthUnited States
  • Challenges in the Early Detection and Management of a Patient at the Interface of Kidney and Heart Disease
    MarisolTorres Toledano Speaker torres.t.marisol@gmail.comIMSS, MEXICO Mexico
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    DebasishBanerjee Speaker St George's University Hospital NHS Foundation TrUnited Kingdom
  • Co-management of Patients With Cardio-Kidney Diseases: Let
    CharlesHerzog Speaker Charles.Herzog@cdrg.orgISN and Hennepin Healthcare/University of MinnesUnited States
  • Q and A
Hall C1

Day 3 - Tuesday April 16, 2024

Time Session
9 a.m.
10 a.m.
DebasishBanerjee Chairperson St George's University Hospital NHS Foundation TrUnited Kingdom
MegJardine Chairperson NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • Setting the Scene
    MegJardine Speaker NHMRC Clinical Trials Centre, University of Sydney, AustraliaAustralia
  • DM and CKD: Which Treatment Should I Use for Different Populations?
    KatherineTuttle Speaker University of Washington School of Medicine, Division of NephrologyUnited States
  • How to Design Studies on Answering Unanswered Questions
    VladoPerkovic Speaker University of New South Wales, Sydney, AustraliaAustralia
  • The Effect of SGLT2 Inhibitors in Patients with Chronic Kidney Disease, With or Without Type 2 Diabetes
    DavidWheeler Speaker University College LondonUnited Kingdom
  • Q and A
Hall C4